A STUDY COMPARING THE EFFECT AND SAFETY OF ONCE WEEKLY DOSING OF SOMAPACITAN WITH DAILY NORDITROPIN® AS WELL AS EVALUATING LONG-TERM SAFETY OF SOMAPACITAN IN A BASKET STUDY DESIGN IN CHILDREN WITH SHORT STATURE EITHER BORN SMALL FOR GESTATIONAL AGE OR WITH TURNER SYNDROME, NOONAN SYNDROME, OR IDIOPATHIC SHORT STATURE

Registry ID

NN8640-4467

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

NOVO NORDISK CANADA INC

Start date

2025-07-17

Last update

2022-05-20

Conditions

• SMALL FOR GESTATIONAL AGE
• IDIOPATHIC SHORT STATURE
• TURNER SYNDROME
• NOONAN SYNDROME

Related clinical trials

• A PHASE 2, RANDOMIZED, HUMAN GROWTH HORMONE-CONTROLLED, MULTICENTER, BASKET STUDY OF VOSORITIDE IN CHILDREN WITH TURNER SYNDROME, SHORT STATURE HOMEOBOX-CONTAINING GENE DEFICIENCY, AND NOONAN SYNDROME WITH AN INADEQUATE RESPONSE TO HUMAN GROWTH HORMONE

View on source registry